Raffi Tachdjian - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Raffi Tachdjian's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Raffi Tachdjian
Verified
Owner, docraffi.com
Los Angeles
Beats
War , Lifestyle , Recipes, Environment , Climate Change , Mental Health, College Students, Life And Arts , Low Income Communities, Politics , Protest Coverage
non for now
Content
Effective long‐term prophylaxis with lanadelumab in adolescents with hereditary angioedema: EMPOWER/ENABLE
By Raffi Tachdjian, Aleena Banerji, Paula J. Busse, Nancy Agmon-Levin| Wiley Online Library Verified There is currently a shortage of data on long-term prophylaxis outcomes in adolescents with hereditary angioedema (HAE). In this study, we employed pooled data from 2 real-world observational studies to assess the effectiveness and safety of lanadelumab in preventing HAE attacks in patients aged 12–17 years with HAE-C1INH.
By Petra Staubach, Raffi Tachdjian, Los Angeles USA, H. Li| Wiley Online Library Verified Garadacimab provided consistent HAE attack prevention in manufacturer-funded post hoc pivotal Phase 3 data analysis. Protection from HAE attacks occurred by Week 1 after first administration.
Effective long‐term prophylaxis with lanadelumab in adolescents with hereditary angioedema: EMPOWER/ENABLE
By Raffi Tachdjian, Aleena Banerji, Paula J. Busse, Nancy Agmon-Levin| Wiley Online Library Verified There is currently a shortage of data on long-term prophylaxis outcomes in adolescents with hereditary angioedema (HAE). In this study, we employed pooled data from 2 real-world observational studies to assess the effectiveness and safety of lanadelumab in preventing HAE attacks in patients aged 12–17 years with HAE-C1INH.
Company Info